Group One Trading’s Novartis NVS Stock Holding History

Group One Trading’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.9M	Sell	110,800 -48,400	-30%	-$7.42M	0.03%	572
2025 Q4	$21.9M	Sell	159,200 -37,800	-19%	-$4.95M	0.04%	491
2025 Q3	$25.3M	Buy	197,000 +64,700	+49%	+$7.89M	0.04%	405
2025 Q2	$16M	Buy	132,300 +105,500	+394%	+$11.9M	0.04%	541
2025 Q1	$2.99M	Sell	26,800 -8,700	-25%	-$926K	0.01%	1477
2024 Q4	$3.45M	Buy	35,500 +26,200	+282%	+$2.79M	0.01%	1445
2024 Q3	$1.07M	Buy	9,300 +4,800	+107%	+$545K	﹤0.01%	2235
2024 Q2	$479K	Sell	4,500 -2,600	-37%	-$261K	﹤0.01%	2603
2024 Q1	$687K	Hold	7,100	–	–	﹤0.01%	2434
2023 Q4	$717K	Sell	7,100 -1,200	-14%	-$116K	﹤0.01%	2770
2023 Q3	$845K	Buy	8,300 +500	+6%	+$50.8K	﹤0.01%	2429
2023 Q2	$787K	Buy	7,800 +3,500	+81%	+$350K	﹤0.01%	2580
2023 Q1	$396K	Sell	4,300 -52,300	-92%	-$4.57M	﹤0.01%	2981
2022 Q4	$5.13M	Buy	56,600 +2,200	+4%	+$185K	0.01%	1128
2022 Q3	$4.13M	Sell	54,400 -22,500	-29%	-$1.87M	0.01%	1310
2022 Q2	$6.5M	Sell	76,900 -28,700	-27%	-$2.52M	0.01%	1111
2022 Q1	$9.27M	Buy	105,600 +1,300	+1%	+$113K	0.01%	1058
2021 Q4	$9.12M	Sell	104,300 -300	-0.3%	-$24.9K	0.01%	1182
2021 Q3	$8.55M	Buy	104,600 +64,500	+161%	+$5.8M	0.01%	1194
2021 Q2	$3.66M	Sell	40,100 -12,500	-24%	-$1.11M	﹤0.01%	2005
2021 Q1	$4.5M	Sell	52,600 -46,700	-47%	-$4.19M	0.01%	1621
2020 Q4	$9.38M	Buy	99,300 +10,800	+12%	+$944K	0.02%	839
2020 Q3	$7.7M	Buy	88,500 +9,200	+12%	+$797K	0.02%	654
2020 Q2	$6.93M	Buy	79,300 +46,100	+139%	+$3.98M	0.03%	606
2020 Q1	$2.74M	Buy	33,200 +4,700	+16%	+$419K	0.02%	845
2019 Q4	$2.7M	Buy	28,500 +2,700	+10%	+$242K	0.02%	1061
2019 Q3	$2.24M	Sell	25,800 -3,800	-13%	-$341K	0.02%	1126
2019 Q2	$2.7M	Buy	29,600 +8,508	+40%	+$720K	0.02%	876
2019 Q1	$1.82M	Sell	21,092 -2,567	-11%	-$206K	0.02%	993
2018 Q4	$1.82M	Buy	23,659 +21,873	+1,225%	+$1.7M	0.02%	1105
2018 Q3	$138K	Buy	1,786 +1,116	+167%	+$82.5K	﹤0.01%	3286
2018 Q2	$45K	Buy	+670	New	+$46.2K	﹤0.01%	4010
2018 Q1	–	Sell	-1,116	Closed	-$84K	–	5174
2017 Q4	$84K	Sell	1,116 -10,937	-91%	-$825K	﹤0.01%	3452
2017 Q3	$927K	Buy	12,053 +7,589	+170%	+$573K	0.01%	1619
2017 Q2	$334K	Sell	4,464 -11,160	-71%	-$791K	﹤0.01%	2261
2017 Q1	$1.04M	Buy	15,624 +2,120	+16%	+$141K	0.01%	1317
2016 Q4	$881K	Buy	13,504 +1,674	+14%	+$109K	0.01%	1394
2016 Q3	$837K	Buy	11,830 +4,241	+56%	+$309K	0.01%	1409
2016 Q2	$561K	Buy	7,589 +4,241	+127%	+$293K	0.01%	1654
2016 Q1	$217K	Buy	3,348 +2,902	+651%	+$197K	﹤0.01%	2266
2015 Q4	$34K	Buy	446 +223	+100%	+$17.7K	﹤0.01%	3637
2015 Q3	$18K	Sell	223 -4,018	-95%	-$358K	﹤0.01%	4081
2015 Q2	$374K	Sell	4,241 -9,709	-70%	-$891K	0.01%	2029
2015 Q1	$1.23M	Buy	13,950 +7,700	+123%	+$683K	0.02%	920
2014 Q4	$519K	Buy	6,250 +4,799	+331%	+$398K	0.01%	1523
2014 Q3	$122K	Sell	1,451 -8,035	-85%	-$650K	﹤0.01%	2820
2014 Q2	$770K	Sell	9,486 -9,598	-50%	-$755K	0.01%	1314
2014 Q1	$1.45M	Sell	19,084 -18,302	-49%	-$1.33M	0.02%	830
2013 Q4	$2.69M	Buy	37,386 +17,744	+90%	+$1.23M	0.04%	487
2013 Q3	$1.35M	Buy	19,642 +11,718	+148%	+$775K	0.03%	789
2013 Q2	$502K	Buy	+7,924	New	+$516K	0.01%	1350

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's NVS Position: Q4 2025 in Review

Group One Trading sold out of Novartis (NVS) in Q4 2025, closing a stake of 2,006 shares — an estimated $263K sold.

Group One Trading first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $1.87M in Q2 2019. 1,508 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

Group One Trading reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 2,006 Novartis shares in Q4 2025, an estimated $263K.
Group One Trading first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
Group One Trading's Novartis position peaked at $1.87M in Q2 2019.
1,508 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.